Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Aoife Ward Gahlawat"'
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract Ovarian cancer (OC) is an aggressive disease, primarily diagnosed in late stages with only 20% of patients surviving more than 5 years. Liquid biopsy markers have great potential to improve current diagnostic and prognostic methods. Here, we
Externí odkaz:
https://doaj.org/article/38343a3e1dcc4100a4c64e962d6e4d77
Autor:
Maria Waltenberger, Jennifer Furkel, Manuel Röhrich, Patrick Salome, Charlotte Debus, Bouchra Tawk, Aoife Ward Gahlawat, Andreas Kudak, Matthias Dostal, Ute Wirkner, Christian Schwager, Christel Herold-Mende, Stephanie E. Combs, Laila König, Jürgen Debus, Uwe Haberkorn, Amir Abdollahi, Maximilian Knoll
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundSelective uptake of (18)F-fluoro-ethyl-tyrosine (18F-FET) is used in high-grade glioma (HGG) to assess tumor metabolic activity via positron emission tomography (PET). We aim to investigate its value for target volume definition, as a progn
Externí odkaz:
https://doaj.org/article/1a8e4bdc966f49b1b3c5337100400bd2
Autor:
Maximilian Knoll, Maria Waltenberger, Jennifer Furkel, Ute Wirkner, Aoife Ward Gahlawat, Ivana Dokic, Christian Schwager, Sebastian Adeberg, Stefan Rieken, Tobias Kessler, Felix Sahm, Laila König, Christel Herold-Mende, Stephanie E. Combs, Jürgen Debus, Amir Abdollahi
Publikováno v:
Cancers, Vol 14, Iss 3, p 684 (2022)
Purpose: To assess the value of whole blood transcriptome data from liquid biopsy (lbx) in recurrent high-grade glioma (rHGG) patients for longitudinal molecular monitoring of tumor evolution under carbon ion irradiation (CIR). Methods: Whole blood t
Externí odkaz:
https://doaj.org/article/0c992c80c9074841828fe18a26112890
Autor:
Aoife Ward Gahlawat, Judith Lenhardt, Tania Witte, Denise Keitel, Anna Kaufhold, Kendra K Maass, Kristian W Pajtler, Christof Sohn, Sarah Schott
Publikováno v:
International Journal of Molecular Sciences, Vol 20, Iss 3, p 704 (2019)
In the last decade, circulating nucleic acids such as microRNAs (miRNAs) and cell-free DNA (cfDNA) have become increasingly important in serving as potential novel biomarkers for a variety of human diseases. If cell-free nucleic acids are to become r
Externí odkaz:
https://doaj.org/article/45d0ef216074427193f436e29e5e38d3
Publikováno v:
British Journal of Cancer. 127:1550-1556
Background Ovarian cancer (OC) is an aggressive disease, primarily diagnosed in late stages with only 20% of patients surviving more than 5 years after diagnosis. There is a pending need to improve current diagnostics and prognostics. Methods In this
Publikováno v:
British Journal of Cancer. 127:156-162
Background Although breast cancer (BC) has a high survival rate, relapse events may occur which ultimately lead to aggressive disease. Circulating cell-free microRNAs (cf-miRNAs) are a promising minimally invasive biomarker with diagnostic and/or pro
Autor:
Anne Schuhn, Tania Witte Tobar, Aoife Ward Gahlawat, Jana Hauke, Lukas Baumann, Jürgen G. Okun, Juliane Nees
Publikováno v:
Archives of gynecology and obstetrics. 306(5)
Purpose Endometrial carcinoma is the second most common gynecological malignancy. Until today lacking a screening tool. A blood-based biomarker could help address this need. Methods The expression levels of 30 acylcarnitines, 18 amino acids, 6 miRNAs
Autor:
Maria Waltenberger, Jennifer Furkel, Manuel Röhrich, Patrick Salome, Charlotte Debus, Bouchra Tawk, Aoife Ward Gahlawat, Andreas Kudak, Matthias Dostal, Ute Wirkner, Christian Schwager, Christel Herold-Mende, Stephanie E. Combs, Laila König, Jürgen Debus, Uwe Haberkorn, Amir Abdollahi, Maximilian Knoll
Publikováno v:
Frontiers in Oncology, 12, Art.Nr. 901390
Front. Oncol. 12:901390 (2022)
Front. Oncol. 12:901390 (2022)
BackgroundSelective uptake of (18)F-fluoro-ethyl-tyrosine (18F-FET) is used in high-grade glioma (HGG) to assess tumor metabolic activity via positron emission tomography (PET). We aim to investigate its value for target volume definition, as a progn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb7be32d52a69ab9786db0216ea8aa82
Autor:
Sara Ciprut, Anne Berberich, Maximilian Knoll, Stefan Pusch, Dirk Hoffmann, Jennifer Furkel, Aoife Ward Gahlawat, Lena Kahlert-Konzelamnn, Felix Sahm, Uwe Warnken, Martin Winter, Martina Schnölzer, Sonja Pusch, Andreas von Deimling, Amir Abdollahi, Wolfgang Wick, Dieter Lemke
Publikováno v:
Neuro-Oncology Advances. 4
Background Targeted immunotherapies are of growing interest in the treatment of various cancers. B7 homolog 3 protein (B7-H3), a member of the co-stimulatory/-inhibitory B7-family, exerts immunosuppressive and pro-tumorigenic functions in various can